том 19 издание 14 страницы 1288-1297

Synergism of three-drug combinations of sanguinarine and other plant secondary metabolites with digitonin and doxorubicin in multi-drug resistant cancer cells

Тип публикацииJournal Article
Дата публикации2012-11-10
scimago Q1
wos Q1
БС1
SJR1.694
CiteScore11.6
Impact factor8.3
ISSN09447113, 1618095X
Drug Discovery
Pharmacology
Pharmaceutical Science
Molecular Medicine
Complementary and alternative medicine
Краткое описание
We determined the ability of some phytochemicals, including alkaloids (glaucine, harmine, and sanguinarine), phenolics (EGCG and thymol), and terpenoids (menthol, aromadendrene, β-sitosterol- O -glucoside, and β-carotene), alone or in combination with the saponin digitonin to reverse the relative multi-drug resistance of Caco-2 and CEM/ADR5000 cells to the chemotherapeutical agent doxorubicin. The IC 50 of doxorubicin in Caco-2 and CEM/ADR5000 was 4.22 and 44.08 μM, respectively. Combination of non-toxic concentrations of individual secondary metabolite with doxorubicin synergistically sensitized Caco-2 and CEM/ADR5000 cells, and significantly enhanced the cytotoxicity of doxorubicin. Furthermore, three-drug combinations (secondary metabolite + digitonin + doxorubicin) were even more powerful. The best synergist was the benzophenanthridine alkaloid sanguinarine. It reduced the IC 50 value of doxorubicin 17.58-fold in two-drug combinations (sanguinarine + doxorubicin) and even 35.17-fold in three-drug combinations (sanguinarine + digitonin + doxorubicin) in Caco-2 cells. Thus synergistic drug combinations offer the possibility to enhance doxorubicin efficacy in chemotherapy.
Найдено 
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.

Топ-30

Журналы

2
4
6
8
10
12
14
Phytomedicine
14 публикаций, 16.09%
Molecules
5 публикаций, 5.75%
Pharmaceutics
3 публикации, 3.45%
Frontiers in Pharmacology
3 публикации, 3.45%
Journal of Medicinal Plants Research
3 публикации, 3.45%
International Journal of Molecular Sciences
2 публикации, 2.3%
Frontiers in Microbiology
2 публикации, 2.3%
Journal of Ethnopharmacology
2 публикации, 2.3%
Drug Development and Industrial Pharmacy
2 публикации, 2.3%
Chemotherapy
1 публикация, 1.15%
PeerJ
1 публикация, 1.15%
American Journal of Chinese Medicine
1 публикация, 1.15%
Future Medicinal Chemistry
1 публикация, 1.15%
Medicines
1 публикация, 1.15%
Foods
1 публикация, 1.15%
Antibiotics
1 публикация, 1.15%
Microorganisms
1 публикация, 1.15%
Cells
1 публикация, 1.15%
Chinese Medicine
1 публикация, 1.15%
BMC Complementary and Alternative Medicine
1 публикация, 1.15%
Acta Pharmacologica Sinica
1 публикация, 1.15%
European Journal of Pharmacology
1 публикация, 1.15%
Biochemical Pharmacology
1 публикация, 1.15%
Biomedicine and Pharmacotherapy
1 публикация, 1.15%
Colloids and Surfaces B: Biointerfaces
1 публикация, 1.15%
Chemico-Biological Interactions
1 публикация, 1.15%
South African Journal of Botany
1 публикация, 1.15%
European Journal of Medicinal Chemistry
1 публикация, 1.15%
Journal of Colloid and Interface Science
1 публикация, 1.15%
2
4
6
8
10
12
14

Издатели

5
10
15
20
25
30
35
Elsevier
34 публикации, 39.08%
MDPI
16 публикаций, 18.39%
Springer Nature
8 публикаций, 9.2%
Wiley
6 публикаций, 6.9%
Frontiers Media S.A.
5 публикаций, 5.75%
Taylor & Francis
4 публикации, 4.6%
Academic Journals
3 публикации, 3.45%
S. Karger AG
1 публикация, 1.15%
PeerJ
1 публикация, 1.15%
World Scientific
1 публикация, 1.15%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 публикация, 1.15%
Royal Society of Chemistry (RSC)
1 публикация, 1.15%
Science Alert
1 публикация, 1.15%
Scientific Research Publishing
1 публикация, 1.15%
Publishing House ABV Press
1 публикация, 1.15%
Microbiology Society
1 публикация, 1.15%
5
10
15
20
25
30
35
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
87
Поделиться
Цитировать
ГОСТ |
Цитировать
Eid S. et al. Synergism of three-drug combinations of sanguinarine and other plant secondary metabolites with digitonin and doxorubicin in multi-drug resistant cancer cells // Phytomedicine. 2012. Vol. 19. No. 14. pp. 1288-1297.
ГОСТ со всеми авторами (до 50) Скопировать
Eid S., El-Readi M. Z., Wink M. Synergism of three-drug combinations of sanguinarine and other plant secondary metabolites with digitonin and doxorubicin in multi-drug resistant cancer cells // Phytomedicine. 2012. Vol. 19. No. 14. pp. 1288-1297.
RIS |
Цитировать
TY - JOUR
DO - 10.1016/j.phymed.2012.08.010
UR - https://doi.org/10.1016/j.phymed.2012.08.010
TI - Synergism of three-drug combinations of sanguinarine and other plant secondary metabolites with digitonin and doxorubicin in multi-drug resistant cancer cells
T2 - Phytomedicine
AU - Eid, Safaa Yehia
AU - El-Readi, Mahmoud Zaki
AU - Wink, Michael
PY - 2012
DA - 2012/11/10
PB - Elsevier
SP - 1288-1297
IS - 14
VL - 19
PMID - 23146422
SN - 0944-7113
SN - 1618-095X
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2012_Eid,
author = {Safaa Yehia Eid and Mahmoud Zaki El-Readi and Michael Wink},
title = {Synergism of three-drug combinations of sanguinarine and other plant secondary metabolites with digitonin and doxorubicin in multi-drug resistant cancer cells},
journal = {Phytomedicine},
year = {2012},
volume = {19},
publisher = {Elsevier},
month = {nov},
url = {https://doi.org/10.1016/j.phymed.2012.08.010},
number = {14},
pages = {1288--1297},
doi = {10.1016/j.phymed.2012.08.010}
}
MLA
Цитировать
Eid, Safaa Yehia, et al. “Synergism of three-drug combinations of sanguinarine and other plant secondary metabolites with digitonin and doxorubicin in multi-drug resistant cancer cells.” Phytomedicine, vol. 19, no. 14, Nov. 2012, pp. 1288-1297. https://doi.org/10.1016/j.phymed.2012.08.010.